Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Atea Pharmaceuticals, Inc. | 767 830 | déclaré | 03 févr. 2026 | tx 26+5 023 985−1 980 496 |
| IDENIX PHARMACEUTICALS INC | 400 000 | déclaré | 10 févr. 2010 | tx 10+1 710 000−269 345 |
| Kezar Life Sciences, Inc. | 26 000 | déclaré | 28 juin 2021 | tx 7+131 631−87 839 |
| ABG Acquisition Corp. I | 0 | déclaré | 01 mars 2023 | tx 1−32 500 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 03 févr. 2026 | EXERCISE | Atea Pharmaceuticals, Inc. | 300 000 | 1.24 USD | |
| 31 janv. 2026 | TAX_WITHHOLDING | Atea Pharmaceuticals, Inc. | 106 093 | 4.24 USD | |
| 31 janv. 2026 | EXERCISE | Atea Pharmaceuticals, Inc. | 272 983 | — | |
| 03 févr. 2026 | EXERCISE | Atea Pharmaceuticals, Inc. | 300 000 | 0.00 USD | deriv |
| 31 janv. 2026 | EXERCISE | Atea Pharmaceuticals, Inc. | 173 466 | 0.00 USD | deriv |
| 31 janv. 2026 | EXERCISE | Atea Pharmaceuticals, Inc. | 99 517 | 0.00 USD | deriv |
| 31 janv. 2025 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 99 517 | — | |
| 31 janv. 2025 | EXERCISE | Atea Pharmaceuticals, Inc. | 173 467 | — | |
| 31 janv. 2025 | TAX_WITHHOLDING | Atea Pharmaceuticals, Inc. | 88 601 | 3.06 USD | |
| 31 janv. 2025 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 440 000 | 0.00 USD | deriv |
| 31 janv. 2025 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 99 518 | 0.00 USD | deriv |
| 31 janv. 2025 | EXERCISE | Atea Pharmaceuticals, Inc. | 173 467 | 0.00 USD | deriv |
| 18 sept. 2024 | SALE | Atea Pharmaceuticals, Inc. | 22 187 | 4.03 USD | |
| 17 sept. 2024 | SALE | Atea Pharmaceuticals, Inc. | 33 941 | 4.05 USD | |
| 19 sept. 2024 | SALE | Atea Pharmaceuticals, Inc. | 1 841 | 4.00 USD | |
| 05 juin 2024 | SALE | Atea Pharmaceuticals, Inc. | 1 006 | 4.00 USD | |
| 31 janv. 2024 | EXERCISE | Atea Pharmaceuticals, Inc. | 173 467 | — | |
| 01 févr. 2024 | SALE | Atea Pharmaceuticals, Inc. | 56 910 | 3.85 USD | |
| 31 janv. 2024 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 448 000 | 0.00 USD | deriv |
| 31 janv. 2024 | EXERCISE | Atea Pharmaceuticals, Inc. | 173 467 | 0.00 USD | deriv |
| 01 mars 2023 | OTHER | ABG Acquisition Corp. I | 32 500 | 0.00 USD | deriv |
| 31 janv. 2023 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 728 600 | 0.00 USD | deriv |
| 31 janv. 2023 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 520 400 | 0.00 USD | deriv |
| 31 janv. 2022 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 378 033 | 0.00 USD | deriv |
| 28 juin 2021 | GRANT_AWARD | Kezar Life Sciences, Inc. | 26 000 | 0.00 USD | deriv |